L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

BACKGROUND: Vitamin D (vitD) and L-arginine have important antimycobacterial effects in humans. Adjunctive therapy with these agents has the potential to improve outcomes in active tuberculosis (TB). METHODS: In a 4-arm randomised, double-blind, placebo-controlled factorial trial in adults with smea...

Description complète

Détails bibliographiques
Auteurs principaux:	Ralph, A, Waramori, G, Pontororing, G, Kenangalem, E, Wiguna, A, Tjitra, E, Sandjaja, Lolong, D, Yeo, T, Chatfield, MD, Soemanto, R, Bastian, I, Lumb, R, Maguire, G, Eisman, J, Price, R, Morris, P, Kelly, P, Anstey, N
Format:	Journal article
Langue:	English
Publié:	Public Library of Science 2013

Documents similaires

Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.
par: Ralph, A, et autres
Publié: (2013)

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: A prospective observational study
par: Pontororing, G, et autres
Publié: (2010)

Tuberculosis outcomes in Papua, Indonesia: the relationship with different body mass index characteristics between papuan and non-Papuan ethnic groups.
par: Enny Kenangalem, et autres
Publié: (2013-01-01)

High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena.
par: Anna P Ralph, et autres
Publié: (2013-01-01)

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study
par: Price Ric N, et autres
Publié: (2010-12-01)

Pharmacokinetics of L-arginine in adults with moderately severe malaria.
par: Yeo, T, et autres
Publié: (2008)

A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics
par: Yeo, T, et autres
Publié: (2013)

Real-time bedside measurement of nitric oxide demonstrates impaired production in adults with severe malaria in papua, Indonesia
par: Lampah, D, et autres
Publié: (2006)

Safety profile of L-arginine infusion in moderately severe falciparum malaria.
par: Yeo, T, et autres
Publié: (2008)

Impaired endothelial function in adults with severe falciparum malaria in Papua, Indonesia
par: Yeo, T, et autres
Publié: (2006)

L-arginine infusion increases no production and reverses endothelial dysfunction in adults with moderately severe falciparum malaria in Papua, Indonesia
par: Yeo, T, et autres
Publié: (2006)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
par: Douglas, N, et autres
Publié: (2014)

Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation.
par: Anstey, N, et autres
Publié: (2007)

Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia.
par: Maguire, G, et autres
Publié: (2005)

Recovery of endothelial function in severe falciparum malaria correlates with recovery of plasma arginine concentrations and fall in blood lactate
par: Yeo, T, et autres
Publié: (2007)

Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.
par: Yeo, T, et autres
Publié: (2007)

Haemolysis, impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria.
par: Yeo, T, et autres
Publié: (2008)

Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations.
par: Yeo, T, et autres
Publié: (2008)

Increased carboxyhemoglobin in adult falciparum malaria is associated with disease severity and mortality.
par: Yeo, T, et autres
Publié: (2013)

Impaired skeletal muscle microvascular function and increased skeletal muscle oxygen consumption in severe falciparum malaria.
par: Yeo, T, et autres
Publié: (2013)

A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics.
par: Tsin W Yeo, et autres
Publié: (2013-01-01)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
par: Lampah, D, et autres
Publié: (2011)

Safety profile of L-arginine infusion in moderately severe falciparum malaria.
par: Tsin W Yeo, et autres
Publié: (2008-06-01)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
par: G. Raghuthaman, et autres
Publié: (2015-10-01)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
par: Yeo, T, et autres
Publié: (2010)

Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria.
par: Yeo, T, et autres
Publié: (2014)

Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.
par: Yeo, T, et autres
Publié: (2008)

ANGIOPOIETIN-2, AN AUTOCRINE MEDIATOR OF ENDOTHELIAL ACTIVATION IS ASSOCIATED WITH PARASITE BIOMASS, ENDOTHELIAL DYSFUNCTION AND MORTALITY IN SEVERE FALCIPARUM MALARIA
par: Yeo, T, et autres
Publié: (2008)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
par: Karyana, M, et autres
Publié: (2007)

Open-label placebos as adjunctive therapy for patients with depression
par: Anne Schienle, et autres
Publié: (2022-08-01)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
par: Tjitra, E, et autres
Publié: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
par: Tjitra, E, et autres
Publié: (2008)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
par: Tjitra, E, et autres
Publié: (2007)

Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.
par: Poespoprodjo, JR, et autres
Publié: (2011)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
par: Poespoprodjo, JR, et autres
Publié: (2014)

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes
par: Poespoprodjo, J, et autres
Publié: (2015)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
par: Price, R, et autres
Publié: (2007)

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
par: Thwaites, GE, et autres
Publié: (2017)

N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial.
par: Charunwatthana, P, et autres
Publié: (2009)

Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.
par: Minigo, G, et autres
Publié: (2009)